Agave salmiana fructans as gut health promoters: Prebiotic activity and inflammatory response in Wistar healthy rats.

Prebiotic effects of Agave salmiana fructans at five different doses were evaluated by the growth of Bifidobacterium, Lactobacillus, and Clostridium strains and SCFA production in the cecum and proximal colon of healthy Wistar rats. Mucosal integrity, bacterial proliferation, and inflammatory response were also examined. Growth of Bifidobacterium and Lactobacillus strains was improved by 12.5% doses of fructans in both cecum and proximal colon tissues, and a significant decrease of Clostridium (P < 0.05) was observed. Increases in mucosal thickness, proliferation, and cell adhesion were mainly observed in the cecum. High concentration of butyric acid and total SCFA were contained in the 12.5% doses. This study provides direct evidence of the prebiotic effects of Agave salmiana fructans, demonstrating that a diet supplemented with a 12.5% dose of fructans promotes major growth of probiotic bacteria and could be used as a potential prebiotic ingredient under the conditions used in this study. Taken together, these results further indicate the significance of Agave salmiana fructans as a prebiotic ingredient in the regulation and prevention of gastrointestinal diseases, as well as for the design of functional foods.

Physiometabolic effects of Agave salmiana fructans evaluated in Wistar rats.

A prospective completely randomized experimental study was conducted using 48 animals to evaluate the physiometabolic effects of Agave salmiana fructans as a dietary supplement in healthy Wistar rats. Five fructans concentrations from 5 to 20% (w/w) and one control were used in the rats' diet and were divided into six groups (n=8 rats/group). The treatments were carried out for 35days, during which glucose, cholesterol, triglycerides, body-weight gain, food intake, fecal excretion, organ weights, renal and hepatic functions and a histological analysis of the cecum were evaluated. Glucose, cholesterol, triglycerides, renal and hepatic functions were not significantly affected by any treatment. Body-weight gain and food intake were lower in the rat groups fed fructans than in the control group. Increased fecal excretion (p<0.05) was observed only in animals fed 12.5 and 20% fructans. Mice supplemented with fructans exhibited increased weight and length (p<0.05) in the cecum and colon. A histological analysis of the cecum showed cellular proliferation with a dose of 12.5% and membrane lysis at doses of 15 and 20%. In conclusion, the inclusion of 12.5% of Agave salmiana fructans in the animals' diets exerts beneficial physiometabolic effects after the seventh treatment day.

Evaluación de la efectividad de la nimodipina en el tratamiento del vértigo de origen periférico: reporte preliminar / Evaluation of the effectiveness of nimodipine in the treatment of vertigo of peripheral origin: preliminary report

El vértigo es un síntoma que se caracteriza por la ilusión de movimiento. Esto afecta tanto el bienestar individual como la capacidad para realizar las actividades propias de la vida cotidiana, ejerciendo un impacto negativo sobre la calidad de vida, por lo tanto es importante encontrar una terapia efectiva y cómoda que permita al paciente incorporarse a las labores de la vida diaria lo mas rápido posible y con la mejor calidad de vida. Métodos: Se evaluó la efectividad en el tratamiento del vértigo de origen periférico de dos formulaciones de nimodipina, la nimodipina convencional de administración tres veces al día (Nimotop® 30 mg) versus la nimodipina 90 mg. AP de administración una vez al día (Tropocer®). Se realizó un estudio clínico prospectivo, aleatorizado, doble ciego, doble simulado (doble dummy), multicéntrico nacional, de grupos paralelos, donde se incluyeron pacientes con vértigo de origen periférico, definido como una puntuación mayor o igual a 7 en el Vertigo-Dizziness Differential Diagnosis Score (VDDDS)¹. Los pacientes fueron evaluados mediante la escala Índice de Severidad del Vértigo2 y el Índice de Discapacidad Vestibular. Resultados: En el grupo de nimodipina AP el Índice de Severidad del Vértigo² disminuyó en un cincuenta por ciento en el 38% de los pacientes a los 14 días, en 53% y 92% a las 4 y 8 semanas respectivamente. El Índice de Discapacidad Vestibular disminuyó en un 50% a los 14 días en el 31% de los pacientes y en 77% y 92% a las 4 y 8 semanas respectivamente. En el grupo de nimodipina convencional el Índice de Severidad del Vértigo disminuyó en un 50% en: 25% de los pacientes a los 14 días, en 67% y 93% a las 4 y 8 semanas respectivamente. El índice de Discapacidad Vestibular disminuyó en 50% a los 14 días en el 30% de los pacientes y en 78% y 100% a las 4 y 8 semanas respectivamente, sin diferencias significativas entre los grupos

Vertigo is a symptom that is characterized by the illusion of movement. It affects both individual welfare and the ability to perform activities of daily living, having a negative impact on quality of life, so it is important to find a comfortable and effective therapy that allows the patient to join the work of the daily life as soon as possible and with the best quality of life. Methods: We evaluated the effectiveness in the treatment of vertigo of peripheral origin of two formulations of nimodipine: conventional nimodipine of administration three times daily (30 mg Nimotop®) versus nimodipine 90 mg. Extender Release (ER) administration once day (ER Tropocer® 90 mg). We performed a prospective, randomized, double-blind, double dummy, national multicenter parallel-group, clinical study which included patients with vertigo of peripheral origin, defined as a score greater than or equal to 7 at the Vertigo-dizziness Differential Diagnosis Score (VDDDS). Patients were evaluated with the scale Index of Severity of Vertigo and Vestibular Disability Index. Results: In the nimodipine ER group, the index of severity of vertigo decreased 50%: in 38% of patients to 14 days in 53% and 92% at 4 and 8 weeks respectively. The vestibular disability index decreased 50% to 14 days in 31% of patients and in 77% and 92% at 4 and 8 weeks respectively. In the nimodipine Conventional group, the index of severi-ty of vertigo decreased in 50% in 25% of patients to 14 days in 67% and 93% at 4 and 8 weeks respectivelyAU)

General anesthesia protocol for the dental patient: emphasis for older adults.

As the population ages, with increased retention of the natural dentition, there will be a greater responsibility for dental professionals to maintain the oral health of medically, behaviorally, cognitively, and physically impaired adults. Oral sedatives and nitrous oxide analgesia are frequently and successfully used for dental treatments in these patients. However, many compromised older adults cannot safely tolerate dental treatment with these sedative techniques in an outpatient setting. This paper describes the use of general anesthesia in a hospital environment, coordinated with medical and anesthesia specialists, that is a viable, safe, and effective treatment tool for providing comprehensive dental and oral surgical treatment for the older patient.

Effect of perezone on arrhythmias and markers of cell injury during reperfusion in the anesthetized rat.

In the in vivo rat heart model with transient (5 min) regional ischemia, as induced by left coronary artery ligation, we have demonstrated that perezone reduces dramatically the incidence of reperfusion-induced-arrhythmias. Administered 5 minutes before coronary occlusion, at a dose of 3.1 mg/kg, this drug effectively protects against the high incidence of arrhythmias and the fall of blood pressure. In addition, it inhibits the release of lactic dehydrogenase and creatine-kinase enzymes to the plasma. We propose that the protective effect of perezone might be related to its well documented action of promoting the release of intramitochondrial Ca2+, thus, maintaining ATP production during reperfusion.

Antimicrobial properties of alkamides present in flavouring plants traditionally used in Mesoamerica: affinin and capsaicin.

The bioactive amides affinin and capsaicin isolated respectively from Heliopsis longipes roots and Capsicum spp fruits, were assayed for activity against Escherichia coli, Pseudomonas solanacearum, Bacillus subtilis and Saccharomyces cerevisicae suspension cultures. The alkamide affinin inhibited growth of E. coli and S. cerevisiae at concentrations as low as 25 microg/ml. Higher concentrations of affinin were necessary to inhibit growth of P. solanacearum and B. subtilis. However. high concentrations of capsaicin only retarded the growth of E. coli and P. solanacearum, whereas growth of B. subtilis was strongly inhibited and that of S. cerevisiae was initially enhanced. Results are discussed in relation to previous reports concerning crude extract and to the molecular structures of the bioactive compounds.

Apparent digestibility of protein and amino acids in broiler chickens fed a corn-soybean diet supplemented with microbial phytase.

The effect of microbial phytase supplementation on CP and amino acid (AA) digestibility was investigated in a 28-d trial using 360 sexed, day-old broiler chickens fed corn-soybean meal diets. The experimental design was a completely randomized one with a 3 x 2 factorial arrangement of treatments. The variables included P and Ca levels and phytase: P and Ca levels were: normal P-normal Ca [0.45% available P (Pa), 1.0% Ca], low P-normal Ca (0.35% Pa, 1.0% Ca), and low P-low Ca (0.35 Pa and 0.6% Ca); and phytase at 0 and 600 U/kg diet. Phytase supplementation increased body weight gain (P < 0.014) and feed intake (P < 0.004) at 19 d in male chickens; in females, phytase increased (P < 0.012) only body weight gain at 19 d. The low P-normal Ca diet reduced (P < 0.05) feed intake and body weight gain in both sexes at 7, 14, and 19 d, compared to the normal P-normal Ca diet; the reduction of Ca in the low P diet prevented the above depression, resulting in body weight gain and feed intake to a level comparable to that of the normal P-normal Ca diet. Microbial phytase supplementation had no effect (P < 0.065) on the apparent ileal digestibility (AID) of CP or any AA except Met and Phe in male broiler chickens. In females, adding phytase increased the AID of all AA except Lys, Met, Phe, and Pro. The low P-normal Ca diet reduced (P < 0.05) the AID of Phe, Asp, and Ser in male chickens and reduced the AID of all the AA except Met and Pro in females compared to the normal P-normal Ca diet. The reduction of Ca in the low P diet prevented the depression of the AID of the AA caused by the low P-normal Ca diet, resulting in AID of AA having a level comparable to that of the normal P-normal Ca diet in both sexes. Phytase supplementation did not have any effect (P > 0.05) on apparent "fecal" digestibility (AFD) of CP or any of the AA in male chickens; however, in female chickens it increased the AFD of Thr, Asp, Glu, and Ser. In summary, phytase supplementation increased growth performance in both sexes; increased AID and AFD of most of the AA, particularly in female chickens. The optimum growth performance and AA digestibilities were obtained with the lowest input of resources, in the low P-low Ca diet supplemented with microbial phytase.

Efficacy of supplemental microbial phytase at different dietary calcium levels on growth performance and mineral utilization of broiler chickens.

A 3-wk feeding trial with 240 sexed, day-old broiler chickens was conducted to determine the efficacy of microbial phytase at different levels of dietary Ca on performance and utilization of minerals in broiler chickens fed a low-P corn-soybean diet. The experimental design was a 3 x 2 factorial arrangement of treatments; Ca at 0.6, 1.0, and 1.25% and phytase at 0 and 600 phytase U/kg diet. Phytase supplementation, regardless of Ca level, increased (P < or = 0.005) feed intake, (P < or = 0.0001) body weight, and (P < or = 0.025) feed efficiency at 21 d; the optimum levels of body weight, feed intake, and feed efficiency were obtained with low (0.6%) dietary Ca plus phytase. Retentions of P, Ca, and N were increased (P < or = 0.05) by phytase supplementation. Although maximum retentions of P and N were obtained at the 1.0 and 1.25% Ca levels, respectively, they were not significantly different from the values obtained at 0.6% Ca. The increasing level of dietary Ca decreased plasma P ( P < or = 0.05) and Cu (P < or = 0.06). Phytase supplementation had the opposite effect; i.e., increased plasma P (P < or = 0.03) and Cu (P < or = 0.02). The maximum level of plasma P was obtained with phytase at the 1.0% Ca level, but this value was not significantly different from the value obtained with phytase at the 0.6% Ca level. Phytase supplementation increased (P < 0.04) the ash content of both tibia head and shaft but had no effect on mineral contents in the ash. The optimum level of ash content was observed with the 0.06% Ca diet plus phytase. The results show that microbial phytase supplementation to a low P diet improved growth performance and mineral utilization in broiler chickens. Dietary Ca levels had a significant effect on the response to phytase; the optimum growth performance and mineral utilization were achieved at the low (0.6%) level of dietary Ca supplemented with phytase.

The effects of supplemental microbial phytase on the performance and utilization of dietary calcium, phosphorus, copper, and zinc in broiler chickens fed corn-soybean diets.

A 3-wk feeding trial with 180 sexed day-old broiler chickens was conducted to study the efficacy of microbial phytase (Natuphos 1000) on growth performance, relative retention of P, Ca, Cu, and Zn, and mineral contents of plasma and bone. Treatments involved a normal P level corn-soybean diet, a low-P diet, and a low-P plus phytase (600 phytase units/kg) diet. Phytase supplementation increased (P < or = 0.05) body weight in male and female chickens by 13.2 and 5.8%, respectively, at 21 d. The improvements yielded body weights comparable to those obtained on the normal P diet. Phytase supplementation overcame (P < or = 0.05) the depression of feed intake observed on the low-P diet. Treatments had no effect on feed:gain ratio. Phytase supplementation of the low-P diet increased (P < or = 0.05) the relative retention of total P, Ca, Cu, and Zn by 12.5, 12.2, 19.3, and 62.3 percentage units, respectively, in male chickens. Microbial phytase increased the plasma P by 15.7% and reduced (P < or = 0.05) the Ca concentration by 34.1%, but had no effect on plasma concentrations of Cu or Zn. Phytase supplementation increased the percentage ash in both head and shaft portions of dry, fat-free tibia bone to a level comparable to that of the normal-P diet. Phytase supplementation had no effect on the concentration of any of the minerals measured in whole tibia ash but did increase (P < or = 0.05) the DM percentage of P and Ca min tibia head of male chickens by 0.65 and 1.4 percentage units, respectively. These results show that microbial phytase supplementation of a low-P diet increased growth and relative retention of total P, Ca, Cu, and Zn and improved bone mineralization in broiler chickens.

Comparative trace mineral nutritional balance of first-litter gilts under two dietary levels of copper intake.

Seven pairs of purebred Landrace first-litter gilts, housed in individual stainless-steel metabolic cages were used in this study. A low-Cu (LCu) basal diet containing only 2 mg/kg of Cu was compared to the control (CCu) diet, which was supplemented with cupric carbonate to provide 10 mg/kg of Cu. Both diets were fed at the rate of 2 kg per day to first-litter gilts during the entire pregnancy. The metabolic response under these two levels of dietary Cu intake was evaluated through nutritional balances conducted for 5 days starting at 30, 60 and 100 days of pregnancy. Total urine collection was done through teflon-coated catheters to the bladder while daily fecal collection was carried out continuously. Water consumption was measured and periodic samples were collected for analysis. Nutritional balances included DM digestibility, Cu, Zn, Fe and Mn. The LCh group consumed 4.26 mg of Cu per day while the CCu received 25 mg of Cu per day. This includes 1 mg per day in the drinking water in both groups. DM digestibility was significantly (P < 0.05) higher during early pregnancy in the LCu group compared to the CCu group, which showed a significant (P < 0.05) increase in DM digestibility from early to late pregnancy period. Dietary Cu intake had a direct effect (p < 0.05) on Cu balance but also altered the Zn and Fe nutritional balance, leaving Mn balance almost unchanged. Feces represented the almost exclusive route of excretion of trace minerals. Regardless of the dietary Cu intake, it represents more than 99.9% of the Fe and Mn, 98% of the Zn and 97% of the Cu was excreted daily through feces plus urine. The nutritional balance of Cu, Zn and Fe, in absolute amounts as well as relative to the level of intake, improved significantly as pregnancy progressed. Although relative retention of the low-Cu group was significantly improved compared to the control group, the absolute amount was still much lower. The well recognized dietary and metabolic interactions of Cu with Zn and Fe were evident in the first-litter gilts receiving the low-Cu diet during pregnancy. The absolute amount, as well as the relative retention as a % of the intake, was increased on average during the entire pregnancy for Zn by more than 70% and for Fe by more than 80% during the last third of pregnancy. In contrast Mn balance was almost unchanged. The major response to low-Cu intake was directed toward greater apparent absorption of the trace minerals which was reflected in a reduced fecal excretion.

The effects of low dietary copper intake during pregnancy on physiological fluids and reproductive performance of first-litter gilts.

Seven pairs of first littermate gilts were used to study the influence of low copper supply and pregnancy on physiological fluids and reproductive performance of first-litter gilts. They were fed semi-purified diets containing either 2.13 or 12.25 micrograms/kg of Cu from 30 days of gestation through two weeks of lactation. Low-Cu gilts had lower plasma Cu in early- and mid- gestation and farrowed piglets with lower plasma Cu and higher plasma Zn concentrations (p < 0.05). Plasma Fe and Mn concentrations were not affected by Cu supply (p > 0.05). Plasma Cu and Fe levels of newborn piglets were lower than those of their dams (p < 0.05) but this was not true for plasma Zn and Mn (p > 0.05). Low-Cu gilts had lower Cu and higher Zn content in colostrum and also lower Cu in milk than control gilts (p < 0.05). No significant differences were found in Fe and Mn levels in colostrum and milk between the two treatments (p > 0.05). Colostrum was richer in Cu and Zn than milk (p < 0.05) but not in Fe and Mn (p > 0.05). The low-Cu diet did not affect (p > 0.05) weight changes during pregnancy. The duration of parturition was shorter for low-Cu than for control gilts (3.19h vs. 5.71h, p < 0.05). Control gilts farrowed larger litters than low-Cu gilts (9.71 vs. 7.57 piglets, p < 0.05). There were no significant differences in live litter weights at birth, one wk. or two wks. of age (p > 0.05). The results indicated that a low-Cu diet and pregnancy had some effect on plasma, colostrum and milk mineral concentrations, as well as on litter size of gilts. An interaction between Cu and Zn was found.

[Ketorolac protection in damage due to myocardial ischemia and reperfusion]. / Protección por Ketorolac en el daño producido por isquemia y reperfusión miocardica.

This study shows that the nonsteroidal anti-inflammatory drug. Ketorolac, has an ionophore-like action for calcium, such a drug may transfer calcium through an hydrophobic phase. This property does not affect the respiratory rate of mitochondria. These results indicate that the ionophoretic effect is not due to an uncoupling action of Ketorolac. The effect of this compound was tested in a reperfusion model where it was observed that Ketorolac (1 mg/Kg weight) administered 30 min before an ischemic period was induced, reverts the arrhythmic effect of reperfusion. These results are in agreement with the analysis of the plasmatic concentrations of the enzymes creatine kinase and lactic dehydrogenase. It was found that the levels of such enzymes were lower in Ketorolac treated group, than in the untreated one. The results clearly indicate that Ketorolac prevents from the myocardial damage induced by reperfusion, probably by avoiding calcium overload in myocytes.

Fluorescamine-induced membrane permeability in mitochondria.

1. Addition of fluorescamine (75 microM) to mitochondria induced an increase in membrane permeability. 2. The leakiness of the inner mitochondrial membrane is characterized by extensive release of accumulated Ca2+, collapse of the transmembrane potential, mitochondrial swelling and efflux of matrix proteins, among them, malate dehydrogenase. 3. These effects were diminished by supplementing the media with 1 mM phosphate, and partially prevented by Mg2+. 4. These results indicate that the primary amino groups of membrane components contribute, partially, to the maintenance of the permeability barrier in mitochondria.

Metabolic activity of manganese during late gestation of first-litter gilts.

Four pairs of littermate Landrace gilts consuming either a low manganese (LMn) basal corn-soya diet (10 mg/kg) or a high Mn (HMn) supplement diet (84 mg/kg) were maintained in individual stainless steel metabolic cages throughout gestation. On the 100th day of gestation 200 microCi of 54Mn was administered intravenously. Total collection of feces and urine was conducted for a seven-day period. The sows were sacrificed after a three-week lactation period and several tissues excised. All samples were assayed for stable Mn content and 54Mn activity. Urinary excretion of 54Mn was negligible and not dependent on dietary Mn intake. Dietary Mn intake did not influence the rate of 54Mn elimination via the feces. The biological half-life (BHL) of the body Mn pool in late gestation averaged 54 days and was not influenced by treatment. The fecal Mn of endogenous origin was similar between treatments averaging 0.24 mg/d and yielded true absorption estimates of 1.31 and 1.61 mg/d for the LMn and HMn diets or 4.41% and 0.77% of dietary intake.

Effect of feeding palmitic, oleic, and linoleic acids to Japanese quail hens (Coturnix coturnix japonica). 1. Reproductive performance and tissue fatty acids.

A study was conducted to evaluate the effects of diets containing 3% of either palmitic acid (Diet PA), oleic acid (Diet OA), or linoleic acid (Diet LA) on reproductive performance, fatty acid composition of egg yolk, plasma, and liver, and total plasma phosphorus of Japanese quail. Each diet was fed to 20 individually caged hens from 5 wk of age. A 24-wk production period started at 8 wk of age. Fertile eggs for incubation were obtained by placing at random a male in the cage with the female for 15 to 20 min twice per week. The males were kept in separate individual cages and fed a turkey grower diet throughout. Feed consumption, egg production, egg output, and the number of chicks per hen were higher (P less than .05) in birds fed Diet PA than in those fed Diet OA or Diet LA. Hatchability was not different (P greater than .05) between Diet PA and Diet OA, but they were higher (P less than .05) than that of Diet LA. Quail weight at hatch from birds fed Diet LA was heavier (P less than .05) than those from Diet OA, but not different (P greater than .05) from those fed Diet PA. Total plasma phosphorus concentration was higher (P less than .05) in birds fed Diet PA than in those fed Diet LA. High levels of oleic and linoleic acids were found in egg yolk, plasma, and liver lipids from birds fed Diet OA and Diet LA, respectively. Feeding Diet PA resulted in elevated levels of palmitoleic acid in all three tissues. The highest overall reproductive performance on Diet PA suggests that palmitic acid has some physiological role in reproduction. The sustained near-maximal levels of egg production and fertility achieved in this trial indicate the superiority of the mating procedure, which would also permit testing the response of male and female birds while minimizing injuries incurred by the females.

Metabolic activity of zinc during late pregnancy and lactation of first-litter gilts and their offspring under low dietary zinc intake.

The metabolism of Zn-65 was studied in littermate gilts fed either low-Zn (10 mg/kg) or Zn-supplemented (50 mg/kg) diets throughout pregnancy and lactation, and dosed with 100 microCi of Zn-65 at 100 days of pregnancy. Zinc-65 appeared earlier in urine of deficient gilts and about the same time after dose in feces of both groups. Total activity and proportion of the dose excreted via feces were higher in supplemented gilts, where as specific activity (SA) of feces was higher in deficient gilts. Excretion of endogenous Zn by supplemented gilts was triple that of deficient gilts whereas true absorption of Zn by deficient gilts was more than 4-fold that of their supplemented littermates. Biological half-life of Zn-65 was 46 d for the control and twice as long in deficient gilts. Total activity and SA of colostrum was higher in deficient gilts. Muscle, followed by liver, retained the highest proportion of the dose in both groups. Proportion of the dose retained in the liver and lungs was higher in control gilts where as Zn-65 retention in brain, heart, lungs and spleen was higher in deficient gilts. Most tissues from deficient gilts showed higher SA. Liver showed the highest Zn-65 concentration in control and lung in low-Zn newborn piglets. At two weeks of age, liver from both groups of piglets showed the highest Zn-65 retention. Proportion of the dose in brain and lungs was higher in deficient piglets. Specific activity of most organs from deficient piglets was higher than that of controls at both ages. Pregnant gilts under low dietary Zn intake made maximum utilization of this mineral by increasing true absorption and reducing endogenous excretion.

[Ulcerative colitis]. / Colitis ulcerosa.

Ulcerative colitis in children has been seldom described in Chile. The cases of a 14 year old girl and a 10 year old boy with this disease are presented. Both had diarrhea for more than two months--which was continuous in the first case and intermittent in the other one--, bloody stools, weight loss, anemia and abdominal pain. Bacteriological and parasitological examination of stools were negative. Diagnosis of ulcerative colitis was based on barium enema, which showed mucosal ulceration and loss of the normal claustral pattern, rectosigmoidoscopy, that revealed hyperemia, friability and erosions of the corresponding segments of intestinal mucosa, and on histological examination of multiple mucosal biopsies, which disclosed crypt abscess, distorted crypt pattern, inflammation of the lamina propria and decreased number of goblet cells. Both cases were treated with salazosulfapyridine with satisfactory response.

Tissue composition and trace mineral content of the dam and litter under low dietary zinc intake during gestation and lactation of first-litter gilts.

Dry matter (DM), fat, calcium (Ca), phosphorus (P), zinc (Zn), copper (Cu), iron (Fe) and manganese (Mn) analyses were performed in tissues from gilts and their offspring after receiving either a control (50 mg/kg) or a low-Zn dietary (10 mg/kg) during gestation and lactation. DM and fat content in the body tissues of the dams were not affected by Zn-intake except in the liver and placenta; liver fat was significantly decreased, while placenta fat was significantly increased in the low-Zn gilts. Several tissues of the dams fed the low-Zn diet showed a lower Zn concentration, but liver and bones were the most significantly affected. Liver from these dams compensated with a significant increase in Cu concentration, while placenta, although not affected in its Zn concentration, showed a significant increase in Mn concentration. Overall, at the end of a two week lactation, first-litter gilts showed a significant reduction in total body Zn content, reaching only 65% of the total Zn found in the control gilts. This was compensated for by a significant increase in the total body Cu content, which was 24% greater than in the control group. In spite of the significant reduction of the total body Zn in the dams fed the low-Zn diet, their newborn and two week old piglets showed a significant reduction in Zn concentration in several tissues, of which the liver and bones were mostly affected. At the same time, liver Cu concentration was significantly increased in these piglets. Curiously, there was also observed a consistent increase in Mn concentration in the brain and bones of these piglets. Total body Zn was reduced by more than 40% in newborn piglets from low-Zn dams. There was a significant increase in total body Zn observed from birth to 2 weeks of age in piglets, 58.4 and 53.4 mg for the control and low-Zn group, respectively. This resulted in no significant differences between the 2 experimental groups at the end of 2 weeks of suckling by their respective dams. This indicated that the colostrum and milk was a good source of Zn regardless of the dietary Zn intake of their dams. Total body Cu in piglets at birth was not found to be significantly different in the 2 groups but, by 2 weeks of age, piglets being sucked by low-Zn dams showed a significantly higher Cu content, with an excess of 50% or more of the Cu content found in control piglets.

Dicyclohexylcarbodiimide as inducer of mitochondrial Ca2+ release.

The effect of the alkylating reagent dicyclohexylcarbodiimide (DCCD) on mitochondrial Ca2+ content was studied. The results obtained indicate that DCCD at a concentration of 100 microM induces mitochondrial Ca2+ efflux. This reaction is accompanied by an increasing energy drain on the system, stimulation of oxygen consumption, and mitochondrial swelling. These DCCD effects can be partially suppressed by supplementing the incubation medium with 1 mM phosphate. By electrophoretic analysis on polyacrylamide-sodium dodecyl sulfate, it was found that DCCD binds to a membrane component with an Mr of 20 to 29 kDa.

The influence of supplemental corn oil and free fatty acids on the reproductive performance of Japanese quail (Coturnix coturnix japonica).

An experiment was conducted to evaluate the effects of dietary corn oil (CO) and commercial free fatty acids on the fatty acid composition of blood plasma and egg yolk lipids and on the reproductive performance of Japanese quail. When quail were fed a semi-purified low-fat basal mix, the substitution of 3% of CO for corn starch (CS) improved egg weight (11.2 versus 10.8 g), reduced late embryonic mortality (16.7 versus 28.4%), and improved hatchability (75.7 versus 64.1%). Diets in which palmitic acid or oleic acid were substituted on a weight basis for 3% of CS performed as well as those in which CO was used. When linoleic acid replaced 3% of CS, late embryonic mortality was reduced (13.7 versus 28.4%) and hatchability was improved (80.1 versus 64.1%), but fertility was depressed (85.8 versus 93.6%). The substitution of linolenic acid for 3% of CS depressed feed consumption, body weight, and egg weight relative to the low-fat CS diet and did not improve the low 18-day embryonic livability and low hatchability. The fatty acid compositions of plasma and yolk were influenced by the lipid composition of the diets. Quail fed 3% of CO deposited more linoleic acid in the egg than those fed 3% of linoleic acid (15.2 versus 11.7%). Thus, quail fed a simplified basal breeder diet containing .6% of linoleic acid showed decreased embryonic livability and hatchability and these parameters achieved normal levels in response to the substitution of 3% of either CO, palmitic acid, oleic acid, or linoleic acid for CS.